Effects of trichostatin A and PXD101 on the in vitro development of mouse somatic cell nuclear transfer embryos
Effects of trichostatin A and PXD101 on the in vitro development of mouse somatic cell nuclear transfer embryos
复制标题
曲古抑菌素A和PXD101对小鼠体细胞核移植胚胎体外发育的影响
DOI:
10.1089/cell.2016.0030
复制
发表时间:
2017
影响因子:
1.6
通讯作者:
Yuemin Li
中科院分区:
文献类型:
--
作者:
Xiaoyan Qiu;Haihong You;Xiong Xiao;Nan Li;Yuemin Li
The low success rate of animal cloning by somatic cell nuclear transfer (SCNT) is believed to be associated with aberrant epigenetic nuclear reprogramming. It has been demonstrated that treatment with histone deacetylase inhibitors (HDACis) enhances developmental potential of SCNT embryos. Previous studies in many species revealed that treatment of SCNT embryos with trichostatin A (TSA)—an HDACi—significantly enhances the.in vitro development of SCNT embryos. In this study, we compared two different SCNT protocols with TSA and investigate, for the first time, the effect of another new HDACi, PXD101 (belinostat), on in vitro development of mouse SCNT embryo. Rates of blastocyst development in mouse SCNT embryos treated with either 5 nM TSA during (6 hours) and after (4 hours) activation (39.1%) or with 50nM PXD101 during (6 hours) and after (4 hours) activation (40.2%) were significantly higher than those of nontreated SCNT embryos (11.5%) and both treatments also significantly improved the subsequent establishment of NT-ESCs in comparison with the nontreated group (38.1% and 40.9% vs. 11.8%). In conclusion, we optimized the TSA concentration and treatment timing and, for the first time, investigated the effect of PXD101 on mouse development of SCNT embryos and establishment of NT-ESCs.